Intergroup trial fails to demonstrate a benefit with the addition of irinotecan to bolus 5-fluorouracil/leucovorin in stage III colon cancer

G. Kesava Reddy, Edward Chu

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)221-232
Number of pages12
JournalClinical colorectal cancer
Volume4
Issue number4
StatePublished - Nov 2004
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Gastroenterology

Cite this